Streetbeat News

LCI

Lannett Co., Inc.

www.lannett.com

CEO

Timothy Crew

Employees

564

Industry

Pharmaceutical Preparation Manufacturing

Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Lucid Group, Inc. (NASDAQ:LCID) reported below-consensus Q3 revenue and lowered its 2023 production guidance, causing a drop in stock price. Despite this, Needham analyst Chris Pierce reiterated a Buy rating on the stock, lowering his price target from $9 to $5. Pierce's optimism is based on Lucid's industry-leading battery and drive-train technology. Lucid delivered 1,457 vehicles and produced 1,550 vehicles in Q3, and lowered its delivery guidance from 10,000+ units to 8,000-8,500 units.

Portfolio Pulse from Shanthi Rexaline

November 08, 2023 | 1:17 pm

Tesla's stock soared 10% amid CEO Elon Musk's visit to China, while Lucid Group's stock slumped due to a common stock offering. Ford announced a partnership with Uber to lease Mustang Mach-E EVs to Uber drivers, and Chinese EV companies Nio, XPeng, and Li Auto reported mixed delivery numbers for May.

Portfolio Pulse from Shanthi Rexaline

June 03, 2023 | 1:14 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.